Ortho Clinical Diagnostics is launching to market its SARS-CoV-2 antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack. This test detects antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus. Soon after, Ortho will also launch an IgG only test: Anti-SARS-CoV-2 IgG Reagent.

Among the following main applications of serology tests, which ones have top priority in your current context? Aid in the diagnosis of suspected COVID-19 patients in conjunction with molecular tests or aid in the management of already diagnosed patients (in hospital use).Monitoring population immunity to progressively reduce containment policies (“back to work” strategies).Screening convalescent patients to use their plasma for therapeutic purposes.Epidemiological research (assessing widespread immunity over time and geographical areas, facilitate contact tracing, monitor “second wave” of infections).Identify vaccine targets, assess vaccine and treatments effectiveness.

First Name

Last Name

Facility

Email

Phone

Country

By submitting this information, I would like to receive information about products, solutions, services, and/or educational events from Ortho Clinical Diagnostics. The information you submit will be governed by our privacy notice.

Comments

PR-06102